Relative mutagenicity and teratogenicity of cyclophosphamide and two of its structural analogs
- 1 December 1983
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 32 (24) , 3791-3795
- https://doi.org/10.1016/0006-2952(83)90151-x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- The in vitro teratogenicity of cyclophosphamide in rat embryosTeratology, 1982
- Teratogenicity of cyclophosphamide metabolites: Phosphoramide mustard, acrolein, and 4-ketocyclophosphamide in rat embryos cultured in vitroToxicology and Applied Pharmacology, 1981
- Investigations on cyclophosphamide treatment during the preimplantation period. II. In vitro studies on the effects of cyclophosphamide and its metabolites 4‐OH‐cyclophosphamide, phosphoramide mustard, and acrolein on blastulation of four‐cell and eight‐cell mouse embryos and on their subsequent development during implantationTeratology, 1981
- Assessment of the teratogenic potential of acrolein and cyclophosphamide in a rat embryo culture systemToxicology, 1981
- Teratogenicity of cyclophosphamide in a coupled microsomal activating/embryo culture systemBiochemical Pharmacology, 1981
- Cyclophosphamide cystitis—Identification of acrolein as the causative agentBiochemical Pharmacology, 1979
- Teratogenic bioactivation of cyclophosphamideLife Sciences, 1979
- In vitro metabolism of cyclophosphamide in limb bud cultureTeratology, 1979
- The problem of specificity and selectivity of alkylating cytostatics; studies on N-2-chloroethylamido-oxazaphosphorinesZeitschrift für Krebsforschung und Klinische Onkologie, 1977
- Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamideBiochemical Pharmacology, 1974